Page 35 - AN-4-4

Advanced Neurology Graphene quantum dots approach in AD

77. Goedert M. Alzheimer’s and Parkinson’s diseases: The prion 2022;17:6621-6638.
concept in relation to assembled Aβ, tau, and α-synuclein. doi: 10.2147/IJN.S388030
Science. 2015;349(6248):1255555.
88. Li Y, Lai W, Zheng C, et al. Neuroprotective effect of
doi: 10.1126/science.1255555
stearidonic acid on amyloid β-induced neurotoxicity in rat
78. Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer’s hippocampal cells. Antioxidants. 2022;11(12):2357.
disease: Pathogenesis, diagnostics, and therapeutics. Int J doi: 10.3390/antiox11122357
Nanomedicine. 2019;14:5541-5554.
89. Puranik N, Yadav D, Song M. Advancements in the
doi: 10.2147/IJN.S200490 application of nanomedicine in Alzheimer disease:
79. Chaparro CI, Simões BT, Borges JP, et al. A promising A therapeutic perspective. Int J Mol Sci. 2023;24(18):14044.
approach: Magnetic nanosystems for Alzheimer’s disease doi: 10.3390/ijms241814044
theranostics. Pharmaceutics. 2023;15(9):2316.
90. Yousaf M, Huang H, Li P, Wang C, Yang Y. Fluorine
doi: 10.3390/pharmaceutics15092316 functionalized graphene quantum dots as inhibitor
80. Guo X, Lie Q, Liu Y, et al. Multifunctional selenium against hIAPP amyloid aggregation. ACS Chem Neurosci.
quantum dots for the treatment of Alzheimer’s disease 2017;8(6):1368-1377.
by reducing Aβ-neurotoxicity and oxidative stress and doi: 10.1021/acschemneuro.7b00015
alleviate neuroinflammation. ACS Appl Mater Interfaces.
2021;13(26):30261-30273. 91. Vatanparast M, Shariatinia Z. Revealing the role of different
nitrogen functionalities in the drug delivery performance
doi: 10.1021/acsami.1c00690 of graphene quantum dots: A combined density functional
81. Chapleau M, Iaccarino L, Soleimani-Meigooni D, theory and molecular dynamics approach. J Mater Chem B.
Rabinovici GD. The role of amyloid PET in imaging 2019;7(40):6156-6171.
neurodegenerative disorders: A review. J Nucl Med. doi: 10.1039/C9TB00971J
2022;63(suppl 1):13S-19S.
92. Li S, Li Y, Cao J, Zhu J, Fan L, Li X. Sulfur-doped graphene
doi: 10.2967/jnumed.121.263195 quantum dots as a novel fluorescent probe for highly
82. Antic SD, Empson RM, Knöpfel T. Voltage imaging to selective and sensitive detection of Fe3+. Anal Chem.
understand connections and functions of neuronal circuits. 2014;86(20):10201-10207.
J Neurophysiol. 2016;116(1):135-152. doi: 10.1021/ac503183y
doi: 10.1152/jn.00226.2016 93. Gessner I, Neundorf I. Nanoparticles modified with
83. Banik M, Ledray AP, Wu Y, Lu Y. Delivering DNA aptamers cell-penetrating peptides: Conjugation mechanisms,
across the blood-brain barrier reveals heterogeneous physicochemical properties, and application in cancer
decreased ATP in different brain regions of Alzheimer’s diagnosis and therapy. Int J Mol Sci. 2020;21(7):2536.
disease mouse models. ACS Cent Sci. 2024;10(7):1585-1593. doi: 10.3390/ijms21072536
doi: 10.1021/acscentsci.4c00563 94. Lo PY, Lee GY, Zheng JH, et al. GFP plasmid and
84. Shimojo M, Higuchi M, Suhara T, Sahara N. Imaging chemoreagent conjugated with graphene quantum dots as a
multimodalities for dissecting Alzheimer’s disease: novel gene delivery platform for colon cancer inhibition in
Advanced technologies of positron emission tomography vitro and in vivo. ACS Appl Bio Mater. 2020;3(9):5948-5956.
and fluorescence imaging. Front Neurosci. 2015;9:482. doi: 10.1021/acsabm.0c00631
doi: 10.3389/fnins.2015.00482 95. Soeda Y, Takashima A. New insights into drug discovery
85. Zhang Y, Ding C, Li C, Wang X. Advances in fluorescent targeting tau protein. Front Mol Neurosci. 2020;13:231.
probes for detection and imaging of amyloid-β peptides in doi: 10.3389/fnmol.2020.590896
Alzheimer’s disease. Adv Clin Chem. 2021;103:135-190.
96. Bharadwaj PR, Dubey AK, Masters CL, et al. Aβ aggregation
doi: 10.1016/bs.acc.2020.08.008 and possible implications in Alzheimer’s disease
86. Meca-Lallana JE, Casanova B, Rodríguez-Antigüedad A, pathogenesis. J Cell Mol Med. 2009;13(3):412-421.
et al. Consensus on early detection of disease progression doi: 10.1111/j.1582-4934.2009.00609.x
in patients with multiple sclerosis. Front Neurol. 97. Arora H, Ramesh M, Rajasekhar K, Govindaraju T.
2022;13:931014.
Molecular tools to detect alloforms of Aβ and tau:
doi: 10.3389/fneur.2022.931014 Implications for multiplexing and multimodal diagnosis of
Alzheimer’s disease. Bull Chem Soc Jpn. 2020;93(4):507-546.
87. Guo F, Li Q, Zhang X, et al. Applications of carbon dots for
the treatment of Alzheimer’s disease. Int J Nanomedicine. doi: 10.1246/bcsj.20190356

Volume 4 Issue 4 (2025) 29 doi: 10.36922/an.7087